Thanks WeM [email protected]
You non-holders, particularly Davisite and Whyte, have been very critical of the company, which is quite OK!
After working for years hand in and with the FDA, and now the CEO is going to get data on the highest (risk and mortality) patients.
I doubt the FDA will tell them to get data on the medium/low (risk and mortality) patients.
Ann: Change in substantial holding, page-60
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |